DK0845034T3 - Peptid med pronociceptive egenskaber - Google Patents

Peptid med pronociceptive egenskaber

Info

Publication number
DK0845034T3
DK0845034T3 DK96927458T DK96927458T DK0845034T3 DK 0845034 T3 DK0845034 T3 DK 0845034T3 DK 96927458 T DK96927458 T DK 96927458T DK 96927458 T DK96927458 T DK 96927458T DK 0845034 T3 DK0845034 T3 DK 0845034T3
Authority
DK
Denmark
Prior art keywords
peptide
nucleic acid
acid molecules
pronociceptive
properties
Prior art date
Application number
DK96927458T
Other languages
Danish (da)
English (en)
Inventor
Marc Parmentier
Gilbert Vassart
Jean-Claude Meunier
Catherine Mollereau
Original Assignee
Euroscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroscreen Sa filed Critical Euroscreen Sa
Application granted granted Critical
Publication of DK0845034T3 publication Critical patent/DK0845034T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96927458T 1995-08-15 1996-08-14 Peptid med pronociceptive egenskaber DK0845034T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US236895P 1995-08-15 1995-08-15
PCT/BE1996/000087 WO1997007208A1 (fr) 1995-08-15 1996-08-14 Molecules d'acide nucleique codant des peptides presentant des proprietes pronociceptives

Publications (1)

Publication Number Publication Date
DK0845034T3 true DK0845034T3 (da) 2003-06-30

Family

ID=21700458

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927458T DK0845034T3 (da) 1995-08-15 1996-08-14 Peptid med pronociceptive egenskaber

Country Status (7)

Country Link
EP (2) EP0845034B1 (fr)
JP (1) JP4191796B2 (fr)
AT (1) ATE233812T1 (fr)
CA (1) CA2229202C (fr)
DE (1) DE69626522T2 (fr)
DK (1) DK0845034T3 (fr)
WO (1) WO1997007208A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0813065A3 (fr) * 1996-06-13 1998-07-22 F. Hoffmann-La Roche Ag Modulation de la fonction d'un récepteur LC-132(analogue à opioide)
CA2206192A1 (fr) * 1996-06-13 1997-12-13 F. Hoffmann-La Roche Ag Modulation de la fonction du recepteur lc132 (opioide)
AU8334298A (en) * 1997-07-15 1999-02-10 Novo Nordisk A/S Nociceptin analogues
WO1999003491A1 (fr) * 1997-07-15 1999-01-28 Novo Nordisk A/S Nouvelle utilisation de nociceptine
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
US6686370B2 (en) * 1999-12-06 2004-02-03 Euro-Celtique S.A. Triazospiro compounds having nociceptin receptor affinity
US8778634B2 (en) 2004-12-01 2014-07-15 Syntaxin, Ltd. Non-cytotoxic protein conjugates
US8399400B2 (en) 2004-12-01 2013-03-19 Syntaxin, Ltd. Fusion proteins
US8603779B2 (en) 2004-12-01 2013-12-10 Syntaxin, Ltd. Non-cytotoxic protein conjugates
US8512984B2 (en) 2004-12-01 2013-08-20 Syntaxin, Ltd. Non-cytotoxic protein conjugates
GB0426394D0 (en) 2004-12-01 2005-01-05 Health Prot Agency Fusion proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677200B2 (en) * 1992-04-10 1997-04-17 Duz Partnership Oligonucleotide sequences and transgenic animals transfectedtherewith having reduced sensitivity to narcotic analgesics
GB9214857D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5747279A (en) * 1993-11-05 1998-05-05 Sloan-Kettering Institute For Cancer Research Nucleic acid molecules encoding kappa3 opioid receptors, receptors encoded thereby, and uses thereof

Also Published As

Publication number Publication date
EP0845034B1 (fr) 2003-03-05
CA2229202C (fr) 2008-05-20
CA2229202A1 (fr) 1997-02-27
EP0845034A1 (fr) 1998-06-03
JP4191796B2 (ja) 2008-12-03
EP1241259A1 (fr) 2002-09-18
WO1997007208A1 (fr) 1997-02-27
ATE233812T1 (de) 2003-03-15
DE69626522T2 (de) 2003-12-24
JPH11511017A (ja) 1999-09-28
DE69626522D1 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
PT662827E (pt) Metodos de diagnostico e composicoes farmaceuticas a base de proteinas notch e acidos nucleicos
PT994728E (pt) Anticorpos recombinantes específicos contra terminações beta-amilóide, codificação por adn e métodos de utilização destes
BG101118A (en) Therapeutical compounds
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
DE59610469D1 (de) Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparate
ATE233812T1 (de) Peptide mit pronociceptiveigenschaften
EP0932613A4 (fr) Blocage de l'expression de l'aggressine dans s. aureus
NO974322L (no) DNA som koder for human papillomvirus type 18
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
BRPI9916549B8 (pt) Composição farmacêutica, proteína, polinucleotídeo
DK1379650T3 (da) Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse heraf
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
PT524421E (pt) Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao
FI973104A0 (fi) Rekombinantti-DNA, joka on valmistettu integroimalla sellainen DNA, joka koodaa myosiinin raskasketju-SM1-isoformiproteiinia vektori-DNA:ssa, sekä tämän rekombinantti-DNA:n sisältävät mikro-organismi ja arterioskleroosilääke
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
SE9604439D0 (sv) New receptor
DK0741746T3 (da) Thymosin alpha 1-analoger
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen